Indication
Tobacco Use Disorder
3 registered trials testing LSD, Psilocybin, Ketamine, DMT for this indication, 1 recruiting now.
3
Registered trials
1
Recruiting
0
In Phase 3
Substances tested
Being studied with
Stay told
When a new trial opens
Trials
All 3 trials for Tobacco Use Disorder
| Trial | Status | Phase | Substance | Sites |
|---|---|---|---|---|
| 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use DisorderNCT05452772 · Johns Hopkins University | Recruiting | Phase 2 | psilocybin | 3 |
| The Effects of Sedatives on Tobacco Use DisorderNCT03813121 · Wake Forest University Health Sciences | Completed | Phase 1 / Phase 2 | ketamine | 1 |
| Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic PsychedelicsNCT06624137 · Yale University | Terminated | N/A | lsd, psilocybin, dmt | 2 |
Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.